Let’s get to it with NUCALA

NUCALA is a prescription medicine for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA). It is the first and only FDA-approved targeted treatment option to help patients with EGPA achieve remission.

Find a doctor near you

See what could happen when NUCALA steps in

Calendar icon

Longer time in complete remission*

fewer icon

Fewer relapses

lower icon

Lower dose of oral steroids (like prednisone)

home icon

At-home administration option every 4 weeks

Results may vary.

*"Complete remission" was defined as no active vasculitis and a prednisone or prednisolone dose less than or equal to 4 mg per day.

"Relapse" was defined as worsening symptoms that required increased steroid dose, and/or increase in dose or start of immunosuppressants, and/or hospitalization.

Curious about taking your medication at home? Learn about a once-monthly, at-home option.
Every 4 weeks.

Discover the Autoinjector

real patient stories

Hear from real people about their journeys with EGPA and their experiences with NUCALA.

Hear their stories

NUCALA autoinjector at-home administration

Use these talking points to have a more open and informed discussion with your doctor.

Download the discussion guide